Wow nobody has come out guns blazing defending the (insert current) CEO saying how wonderful (insert current) CEO is and how much better they are then any previous CEO.
Things have changed.
The "unbiased" quaterly cash inflows also seem to have stopped. They were quite funny actually, reminded me of this with the CFP carrot always just another quarter away:
The fact that they only appeared when they showed what everyone wanted to see certainly puts the lie to the use of the word "unbiased". Cherry picked statistics are never anything else.
Anyway lets hope they get Alexiflam NF registered soon and they can return to revenue growth with some new customers. It's looking pretty expensive at the moment for the current shrinking revenue pools. The change from NCs strategy to DVHs was expensive. A lot of CR was wasted in the process.
General discussion, page-574
-
- There are more pages in this discussion • 817 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
